Koletzko, L.* ; Klucker, E.* ; Le Thi, T.G.* ; Breiteneicher, S.* ; Rubio-Acero, R.* ; Neuhaus, L.* ; Stark, R.G. ; Standl, M. ; Wieser, A.* ; Török, H.* ; Koletzko, S.* ; Schwerd, T.*
Following pediatric and adult ibd patients through the COVID-19 pandemic: Changes in psychosocial burden and perception of infection risk and harm over time.
J. Clin. Med. 10:4124 (2021)
Felix, J. ; Stark, R.G. ; Teuner, C.M. ; Leidl, R. ; Lennerz, B.* ; Brandt, S.* ; von Schnurbein, J.* ; Moss, A.* ; Bollow, E.* ; Sergeyev, E.* ; Mühlig, Y.* ; Wiegand, S.* ; Holl, R.W.* ; Reinehr, T.* ; Kiess, W.* ; Scherag, A.* ; Hebebrand, J.* ; Wabitsch, M.* ; Holle, R.
Health related quality of life associated with extreme obesity in adolescents - results from the baseline evaluation of the YES-study.
Health Qual. Life Outcomes 18:58 (2020)
Olm, M. ; Stark, R.G. ; Beck, N.* ; Röger, C.* ; Leidl, R.
Impact of interventions to reduce overnutrition on healthcare costs related to obesity and type 2 diabetes: a systematic review.
Nutr. Rev. 78, 412-435 (2020)
Kähm, K. ; Stark, R.G. ; Laxy, M. ; Schneider, U.* ; Leidl, R.
Assessment of excess medical costs for persons with type 2 diabetes according to age groups: An analysis of German health insurance claims data.
Diabetic Med., DOI: 10.1111/dme.14213 (2019)
Bamberger, C.* ; Rossmeier, A.* ; Lechner, K.* ; Wu, L.* ; Waldmann, E.* ; Fischer, S.* ; Stark, R.G. ; Altenhofer, J.* ; Henze, K.* ; Parhofer, K.G.*
A walnut-enriched diet affects gut microbiome in healthy caucasian subjects: A randomized, controlled trial.
Nutrients 10:244 (2018)
Huber, M.B. ; Präger, M. ; Coyle, K.* ; Coyle, D.* ; Lester-George, A.* ; Trapero-Bertran, M.* ; Nemeth, B.* ; Cheung, K.L.* ; Stark, R.G. ; Vogl, M. ; Pokhrel, S.* ; Leidl, R.
Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: Results from the EQUIPTMOD.
Addiction 113, 1, 52-64 (2018)
Lennerz, B.S.* ; Moss, A.* ; von Schnurbein, J.* ; Bickenbach, A.* ; Bollow, E.* ; Brandt, S.* ; Luetke-Brintrup, D.* ; Mühlig, Y.* ; Neef, M.* ; Ose, C.* ; Remy, M.* ; Stark, R.G. ; Teuner, C.M. ; Wolters, B.* ; Kiess, W.* ; Scherag, A.* ; Reinehr, T.* ; Holl, R.W.* ; Holle, R. ; Wiegand, S.* ; Hebebrand, J.* ; Wabitsch, M.*
Do adolescents with extreme obesity differ according to previous treatment seeking behavior? The Youth with Extreme obesity Study (YES) cohort.
Int. J. Obes., DOI: 10.1038/s41366-018-0237-4 (2018)
Bamberger, C.* ; Rossmeier, A.* ; Lechner, K.* ; Wu, L.* ; Waldmann, E.* ; Stark, R.G. ; Altenhofer, J.* ; Henze, K.* ; Parhofer, K.G.*
A walnut-enriched diet reduces lipids in healthy caucasian subjects, independent of recommended macronutrient replacement and time point of consumption: A prospective, randomized, controlled trial.
Nutrients 9:1097 (2017)
Timmer, A.* ; Stark, R.G. ; Peplies, J.* ; Classen, M.* ; Laass, M.W.* ; Koletzko, S.*
Current health status and medical therapy of patients with pediatric-onset inflammatory bowel disease: A survey-based analysis on 1280 patients aged 10-25 years focusing on differences by age of onset.
Eur. J. Gastroenterol. Hepatol. 29, 1276-1283 (2017)
Laxy, M. ; Stark, R.G. ; Peters, A. ; Hauner, H.* ; Holle, R. ; Teuner, C.M.
The non-linear relationship between BMI and health care costs and the resulting cost fraction attributable to obesity.
Int. J. Environ. Res. Public Health 14:984 (2017)
Yates, N. ; Teuner, C.M. ; Hunger, M. ; Holle, R. ; Stark, R.G. ; Laxy, M. ; Hauner, H.* ; Peters, A. ; Wolfenstetter, S.B.
The economic burden of obesity in Germany: Results from the population-based KORA studies.
Obes. Facts 9, 397-409 (2016)
Xu, T. ; Brandmaier, S. ; Messias, A.C. ; Herder, C.* ; Draisma, H.H.* ; Demirkan, A.* ; Yu, Z. ; Ried, J.S. ; Haller, T.* ; Heier, M. ; Campillos, M. ; Fobo, G. ; Stark, R.G. ; Holzapfel, C.* ; Adam, J. ; Chi, S. ; Rotter, M. ; Panni, T. ; Quante, A.S. ; He, Y.* ; Prehn, C. ; Römisch-Margl, W. ; Kastenmüller, G. ; Willemsen, G.* ; Pool, R.* ; Kasa, K.* ; van Dijk, K.W.* ; Hankemeier, T.* ; Meisinger, C. ; Thorand, B. ; Ruepp, A. ; Hrabě de Angelis, M. ; Li, Y.* ; Wichmann, H.-E. ; Stratmann, B.* ; Strauch, K. ; Metspalu, A.* ; Gieger, C. ; Suhre, K. ; Adamski, J. ; Illig, T. ; Rathmann, W.* ; Roden, M.* ; Peters, A. ; van Duijn, C.M.* ; Boomsma, D.I.* ; Meitinger, T. ; Wang-Sattler, R.
Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes.
Diabetes Care 38, 1858-1867 (2015)
Laxy, M. ; Hunger, M. ; Stark, R.G. ; Meisinger, C. ; Kirchberger, I. ; Heier, M. ; von Scheidt, W.* ; Holle, R.
The burden of diabetes mellitus in patients with coronary heart disease: A methodological approach to assess quality-adjusted life-years based on individual-level longitudinal survey data.
Value Health 18, 969-976 (2015)
Laxy, M. ; Stark, R.G. ; Meisinger, C. ; Kirchberger, I. ; Heier, M. ; von Scheidt, W.* ; Holle, R.
The effectiveness of German Disease Management Programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: Results from an observational longitudinal study.
Diabetol. Metab. Syndr. 7:77 (2015)
Schunk, M. ; Stark, R.G. ; Reitmeir, P. ; Meisinger, C. ; Holle, R.
Towards patient-oriented diabetes care: Results from two KORA surveys in Southern Germany:
J. Diabetes Res. 2015:368570 (2015)
Stark, R.G. ; Kirchberger, I. ; Hunger, M. ; Heier, M. ; Leidl, R. ; von Scheidt, W.* ; Meisinger, C. ; Holle, R.
Improving care of post-infarct patients: Effects of disease management programmes and care according to international guidelines.
Clin. Res. Cardiol. 103, 237-245 (2014)
Wu, L.* ; Piotrowski, K.* ; Rau, T.T.* ; Waldmann, E.* ; Broedl, U.C.* ; Demmelmair, H.* ; Koletzko, B.* ; Stark, R.G. ; Nagel, J.M.* ; Mantzoros, C.S.* ; Parhofer, K.G.*
Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: A randomized controlled cross-over clinical trial.
Metabolism 63, 382-391 (2014)
Icks, A.* ; Claessen, H.* ; Strassburger, K.* ; Tepel, M.* ; Waldeyer, R.* ; Chernyak, N.* ; Albers, B.* ; Baechle, C.* ; Rathmann, W.* ; Meisinger, C. ; Thorand, B. ; Hunger, M. ; Schunk, M. ; Stark, R.G. ; Rückert, I.-M. ; Peters, A. ; Huth, C. ; Stöckl, D. ; Giani, G.* ; Holle, R.
Drug costs in prediabetes and undetected diabetes compared with diagnosed diabetes and normal glucose tolerance: Results from the population-based KORA survey in Germany.
Diabetes Care 36, 53-54 (2013)
Nagel, J.M.* ; Bücker, S.* ; Wood, M.* ; Stark, R.G. ; Göke, B.* ; Parhofer, K.G.* ; Allgayer, H.*
Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: An unexpected finding?
Exp. Clin. Endocrinol. Diabet. 120, 224-228 (2012)
Leidl, R. ; Reitmeir, P. ; König, H.-H.* ; Stark, R.G.
The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease.
Value Health 15, 151-157 (2012)
Stark, R.G. ; Schunk, M. ; Holle, R.
Ergebnisse der KORA-Studien.
In: Günster, C.* ; Klose, J.* ; Schmacke, N.* [Eds.]: Versorgungsreport 2011. Schwerpunkt: Chronische Erkrankungen. Stuttgart: Schattauer, 2011. 78-82
Stark, R.G. ; John, J. ; Leidl, R.
Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approach.
BMC Health Serv. Res. 11:9 (2011)
Bähr, I.N.* ; Tretter, P.* ; Krüger, J.* ; Stark, R.G. ; Schimkus, J.* ; Unger, T.* ; Kappert, K.* ; Scholze, J.* ; Parhofer, K.G.* ; Kintscher, U.*
High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome.
Hypertension 58, 725-732 (2011)
Stark, R.G. ; Schunk, M. ; Meisinger, C. ; Rathmann, W.* ; Leidl, R. ; Holle, R.
Medical care of type 2 diabetes in German disease management programmes: A population-based evaluation.
Diabetes Metab. Res. Rev. 27, 383-391 (2011)
Schunk, M. ; Stark, R.G. ; Reitmeir, P. ; Rathmann, W.* ; Meisinger, C. ; Holle, R.
Verbesserungen in der Versorgung von Patienten mit Typ-2-Diabetes? Gepoolte Analyse dreier bevölkerungsbasierter Studien (KORA) in der Region Augsburg zwischen 1999 und 2008.
Bundesgesundheitsbl.-Gesund. 54, 1187-1196 (2011)
Parhofer, K.G.* ; Zeymer, U.* ; Stark, R.G. ; Binz, C.* ; Schwertfeger, M.* ; Bhatt, D.L.* ; Steg, P.G.* ; Röther, J.*
In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis - results from the REACH registry.
Exp. Clin. Endocrinol. Diabet. 118, 51-56 (2010)
Findeisen, H.M.* ; Weckbach, S.* ; Stark, R.G. ; Reiser, M.F.* ; Schoenberg, S.O.* ; Parhofer, K.G.*
Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus.
Cardiovasc. Diabetol. 9:44 (2010)
Stark, R.G. ; Reitmeir, P. ; Leidl, R. ; König, H.-H.*
Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.
Inflamm. Bowel Dis. 16, 42-51 (2010)
Lehrke, M.* ; Becker, A.* ; Greif, M.* ; Stark, R.G. ; Laubender, R.P.* ; von Ziegler, F.* ; Lebherz, C.* ; Tittus, J.* ; Reiser, M.* ; Becker, C.* ; Göke, B.* ; Leber, A.W.* ; Parhofer, K.G.* ; Broedl, U.C.*
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.
Eur. J. Endocrinol. 161, 339-344 (2009)
Broedl, U.C.* ; Lebherz, C.* ; Lehrke, M.* ; Stark, R.G. ; Greif, M.* ; Becker, F.* ; von Ziegler, A.* ; Tittus, J.* ; Reiser, M.* ; Becker, C.* ; Göke, B.* ; Parhofer, K.G.* ; Leber, A.W.*
Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.
PLoS ONE 4:e4733 (2009)
Stark, R.G. ; Schunk, M. ; Leidl, R. ; Meisinger, C. ; Holle, R.
Prozessevaluation von Disease Management Programmen bei Typ 2 Diabetes auf Basis einer bevölkerungsrepräsentativen Studie in der Region Augsburg (KORA).
Betr.-wirtschaftl. Forsch. u. Prax. 61, 283-302 (2009)
Weckbach, S.* ; Findeisen, H.M.* ; Schoenberg, S.O.* ; Kramer, H.* ; Stark, R.G. ; Clevert, D.A.* ; Reiser, M.F.* ; Parhofer, K.G.*
Systemic cardiovascular complications in patients with long-standing diabetes mellitus: Comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography.
Invest. Radiol. 44, 242-250 (2009)
Lehrke, M.* ; Konrad, A.* ; Schachinger, V.* ; Tillack, C.* ; Seibold, F.* ; Stark, R.G. ; Parhofer, K.G.* ; Broedl, U.C.*
CXCL16 is a surrogate marker of inflammatory bowel disease.
Scand. J. Gastroenterol. 43, 283-288 (2008)
Broedl, U.C.* ; Schachinger, V.* ; Lingenhel, A.* ; Lehrke, M.* ; Stark, R.G. ; Seibold, F.* ; Göke, B.* ; Kronenberg, F.* ; Parhofer, K.G. ; Konrad-Zerna, A.*
Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease.
Inflamm. Bowel Dis. 13, 391-397 (2007)
Konrad, A.* ; Lehrke, M.* ; Schachinger, V.* ; Seibold, F.* ; Stark, R.G. ; Ochsenkühn, T.* ; Parhofer, K.G.* ; Göke, B.* ; Broedl, U.C.*
Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Eur. J. Gastroenterol. Hepatol. 19, 1070-1074 (2007)
Stark, R.G. ; König, H.-H.* ; Leidl, R.
Costs of inflammatory bowel disease in Germany.
Pharmacoeconomics 24, 797-814 (2006)
Stark, R.G. ; König, H.H.* ; Leidl, R.
Kosten und gesundheitliche Effekte messen - KB Chronisch entzündliche Darmerkrankungen (KB-CED).
In: Von der Forschung in die Versorgung : Kompetenznetze in der Medizin. Bonn: Bundesministerium für Bildung und Forschung, 2006. 78-79
Stark, R.G. ; König, H.H. ; Leidl, R.
Kosten und gesundheitliche Effekte messen - KN Chronisch entzündliche Darmerkrankung / KN-CED.
In: Proceedings (Von der Forschung in die Versorgung - Kompetenznetze in der Medizin). Berlin: Bundesministerium für Bildung und Forschung (BMBF) [Hrsg.], 2006. 78-79
Mühlberger, N.* ; Behrend, C. ; Stark, R.G. ; Holle, R.
Datenbankgestützte Online-Erfassung von Arzneimitteln im Rahmen gesundheitswissenschaftlicher Studien - Erfahrungen mit der IDOM-Software.
In: Informatik, Biometrie und Epidemiologie in Medizin und Biologie. München: Urban & Fischer, 2003. 601-611 ( ; 34)